The process of obtaining a drug patent can be daunting, especially for those without a background in law or intellectual property. However, understanding the intricacies of this process is crucial for pharmaceutical companies seeking to protect their i…
Demystifying the Drug Patent Application Process Read Post »
In the fiercely competitive pharmaceutical industry, securing and enforcing patents is crucial for recouping the massive investments required to bring […]
Source
Enforcing Your Drug Patent: Innovative Strategies Read Post »
ALOXI (palonosetron hydrochloride) Helsinn hlthcare Patent: 7,947,725 Expiration: Jul 30, 2024 See More … For more information on how DrugPatentWatch […]
Source
Drug Patent Expirations for the Week of July 28, 2024 Read Post »
Dabigatran etexilate mesylate is the generic ingredient in two branded drugs marketed by Alkem Labs Ltd, Apotex, Hetero Labs Ltd […]
Source
New tentative approval for Alembic drug dabigatran etexilate mesylate Read Post »
This chart shows the pharmaceutical companies with the most powder dosed drugs. For a different perspective, see the most popular […]
Source
Which pharmaceutical companies have the most powder dosed drugs? Read Post »
Patient advocacy groups have become increasingly influential in the pharmaceutical industry, particularly in the development of generic drugs. These groups, […]
Source
The Role of Patient Advocacy Groups in Generic Drug Development Read Post »
The Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS) sets minimum standards for intellectual property protection globally, including patents […]
Source
The Impact of International Trade Agreements on Drug Patents: A Systematic Review Read Post »
The Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS) sets minimum standards for intellectual property protection globally, including patents […]
Source
The Impact of International Trade Agreements on Drug Patents: A Systematic Review Read Post »
ALOXI (palonosetron hydrochloride) Helsinn hlthcare Patent: 7,947,725 Expiration: Jul 30, 2024 See More … For more information on how DrugPatentWatch […]
Source
Drug Patent Expirations for the Week of July 28, 2024 Read Post »
Annual Drug Patent Expirations for NASCOBAL Nascobal is a drug marketed by Par Pharm and Endo Pharms Inc and is […]
Source
New patent expiration for Endo Pharms drug NASCOBAL Read Post »
Get new actionable insights and updates from BiotechBlog
